MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2022 International Congress

    Prevalence of Movement Disorders After Acute Stroke: a Large Prospective Cohort Stroke Study

    MS. Rocha, L. Alves, J. Tatsch, H. Bezerra, J. Freitas, I. Torres, J. de Paula, P. Marques, P. Matos (SAO PAULO, Brazil)

    Objective: To ascertain the prevalence of acute post-stroke movement disorders (PSMD) in a prospective cohort of acute stroke patients. Background: Post-stroke movement disorders can occur…
  • 2022 International Congress

    Plasma biomarkers of disease progression in Parkinson’s disease

    A. Lupini, N. Ashton, A. Pilotto, B. Battaglio, C. Zatti, S. Gipponi, E. Cottini, I. Grossi, A. Salvi, G. de Petro, M. Pizzi, K. Blennow, H. Zetterberg, A. Padovani (Brescia, Italy)

    Objective: To identify the ability of a panel of plasma biomarkers to predict disease progression in PD patients Background: Plasma neurofilament light chain (NfL) has…
  • 2022 International Congress

    Treatment Selection in Multi-Arm Multi-Stage Clinical Trials in Parkinson Disease: The Search for the Ideal Neuroprotective Drug

    C. Gonzalez-Robles, D. Byrom, R. Chapman, D. Dexter, S. Duty, R. Ellis-Doyle, E. Jabbari, G. Mills, H. Mortiboys, J. Rudiger, E. Sammler, P. Scurfield, S. Stott, G. Tofaris, L. Wei, A. Wong, ML. Zeissler, C. Carroll, T. Foltynie, O. Bandmann, A. Schapira (London, United Kingdom)

    Objective: The Edmond J Safra Accelerating Clinical Trials in Parkinson disease (PD) initiative (EJS ACT-PD) aims to accelerate the identification of disease modifying treatments for…
  • 2022 International Congress

    Caregiver’s burden in Parkinson’s disease: A mixed methods study

    AD. van Halteren, WM. Kapelle, CJ. Sederel, MJ. Meinders, M. Munneke, BRB. Bloem, SKL. Darweesh (Nijmegen, Netherlands)

    Objective: This study had a two-fold aim: (i) to assess how characteristics of informal caregivers and people with PD affect caregiver burden and (ii) to…
  • 2022 International Congress

    Mapping Side Effects in Deep Brain Stimulation – Different Approaches, Different Problems.

    TA. Dembek, H. Jergas, JN. Petry-Schmelzer, C. Baldermann, J. Strelow, A. Nehls, V. Visser-Vandewalle, MT. Barbe (Cologne, Germany)

    Objective: This study aims to evaluate different strategies to map DBS‑induced side‑effects regarding their ability to create anatomically plausible stimulation maps and to predict side‑effect…
  • 2022 International Congress

    Wearable Sensors for Quantitative Motor Assessments in Multiple System Atrophy

    D. Claassen, J. Iregui, A. Wynn, C. Davis, C. Wong, D. Stamler (Nashville, USA)

    Objective: To determine the utility of quantitative wearable sensors in Multiple system atrophy (MSA). Background: Symptoms of MSA include parkinsonism, ataxia, and/or failure of the…
  • 2022 International Congress

    Surgical outcomes in Rare Movement Disorders: A report of seventeen patients from India

    VV. Holla, D. Dhar, N. Kamble, R. Yadav, D. Srinivas, PK. Pal (Bengaluru, India)

    Objective: To study the outcome of functional neurosurgery among patients with Rare movement disorders (RMDs). Background: RMDs throw remarkable challenges to their appropriate management particularly…
  • 2022 International Congress

    Genome-wide association study of Aβ, t-tau and p-tau in CSF in Parkinson’s disease

    H. Iwaki (Bethesda, USA)

    Objective: To investigate genetic contributions to the Alzheimer’s disease (AD) related cerebrospinal fluid (CSF) biomarkers in the patients with Parkinson’s disease (PD). Background: Aβ, t-tau…
  • 2022 International Congress

    Hemichorea-hemiballismus following treatment of Intracranial tuberculomas and tuberculous meningitis

    A. Singh, N. Bansal, S. Shivangi, R. Gupta, J. Singhvi, J. Kaur (Mohali, India)

    Objective: To present a case of right-sided hemichorea-hemiballismus that occurred following treatment of intracranial tuberculomas and tuberculous meningitis Background: A 56-year-old lady presented in the…
  • 2022 International Congress

    Safinamide adherence: the experience of the movement disorder unit of Trieste.

    M. Catalan, M. Liccari, V. Tommasini, L. Antonutti, P. Manganotti (Trieste, Italy)

    Objective: Describe the clinical experience with Safinamide and assess the patients’ adherence to this treatment in the movement disorders centre of Trieste-Italy. Background: Safinamide (Xadago®)…
  • « Previous Page
  • 1
  • …
  • 791
  • 792
  • 793
  • 794
  • 795
  • …
  • 1942
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley